Objective: To observe the clinical efficacy of entecavir in combination with Liuweiwuling tablets in the treatment of HBV-related hepatocirrhosis in compensated stage. Methods: Eighty seven cases of HBV-related hepatocirrhosis patients were randomly divided into two groups. The treatment group( n = 47cases) were treated with entecavir( 0. 5mg / d,oral) combined with Liuweiwuling tablets( 1. 5g,tid.,oral),while the control group( n = 40cases) were given entecavir only( 0. 5mg / d,oral). Both groups were trea...